EFPIA - NEWSLETTER

EFPIA Newsletter 31 March 2022

News

05 October 2022 Pharmaceutical industry response to the war in Ukraine

Supporting people affected by the war

Blogs

31 March 2022 2022 – A key year to put the fight against cancer at the top of the EU political agenda? (1)...

Learning from the past, do better in the future addressing the whole cancer pathway

Videos

How can AI help accelerate drug discovery?

An interview with Regina Barzilay, Distinguished Professor of AI and Health at MIT Jameel Clinic and the School of Engineering and Reza Olfati-Saber, Global Head of AI and Data Analytics at Sanofi R&D

Innovate or stagnate

As a region we can chose to innovate or stagnate, and if innovation happens elsewhere then high value, highly skilled jobs, research investment and advanced manufacturing will move with it.

Regulatory Road to Innovation

As the EU reviews its Pharmaceutical Strategy, we must seize the once in a generation opportunity to create an attractive innovation ecosystem for the next generation of medicines, diagnostics and vaccines. Discover our #RegulatoryRoadToInnovation

We published

EFPIA’s Regulatory Road to Innovation Could Help Restore Europe as World Leader 19 March 2022 (The Lancet, in kiosks)

EFPIA’s Regulatory Road To Innovation – Back To The Cutting Edge 29 March 2022 (Pink Sheet)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶